We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

MiRacle Consortium Receives a € 1.2 Million FP7 Grant from the European Union

Therapeutic development of cancer cell-specific targeting of novel tumor-selective lethal miRNAs for the treatment of head and neck cancer – acronym: MiRacle.

Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R

Canbex Therapeutics Ltd has commenced trials to assess safety and tolerability in humans of VSN16R, its lead compound for multiple sclerosis.

TVM Capital to Focus on Life Science Venture and Healthcare Private Equity Investing Only

Two independent investment teams to focus on Western Europe and North America and the MENA region.

Cancer Research Technology and Nuevolution Sign Multi-Target Deal

Cancer Research Technology (CRT) have signed a collaboration deal to discover anti-cancer drug molecules targeting several key proteins.

Cambridge Crystallographic Data Centre (CCDC) and Rutgers Partner

New partnership sees the CCDC establish operations in North America housed within the CIPR alongside the RCSB Protein Data Bank.

Alnylam Files CTA to Initiate a Phase I Study for ALN-AT3

Company expects to initiate phase I study in early 2014 with interim data from hemophilia subjects by year-end 2014.

Stem Cell Therapeutics Receives U.S. Orphan Drug Designation

Company receives drug designation for the use of tigecycline to treat AML.

NIH Scientists Develop Candidate Vaccine Against Respiratory Syncytial Virus

Structure-based design may be key to successful vaccine for common childhood illness.

Noble Life Sciences Animal Facility Awarded Full AAALAC Accreditation

Company is currently licensed by the United States Department of Agriculture.

UC Develops Unique Nano Carrier to Target Drug Delivery to Cancer Cells

Researchers have developed a unique nanostructure that can, because of its dual-surface structure, serve as an improved “all-in-one tool” against cancer.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter